Table 1

Summary of studies included in these analyses

Name of studyCountryYearAge rangen*Measures available
ARIC (10)U.S.1993–1995 (visit 3)49–7310,873FPG
AusDiab (5)Australia1999–200025–902,052FPG, 2-h PG, A1C
BMES (11)Australia1992–199445–972,915FPG
CURES (12)India2002–2004 (phase III)20–852,200FPG, 2-h PG, A1C
Hiroshima study (4)Japan1990–200417–9912,873FPG, 2-h PG, A1C
MESA (14)U.S.2002–2004 (second examination)45–855,920FPG, A1C
NHANES III (15)U.S.1988–199440–742,869FPG, 2-h PG, A1C
Pima Indian study (17)U.S.1982 (first examination)15–851,829FPG, 2-h PG
SiMES (18)Singapore200440–793,170A1C
  • *Number of participants aged 20–79 years included in the analysis.